Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells

AMP-activated kinase; AMPK silencing; Cell growth; P70S6 kinase; Pituitary tumour; Rapamycin; AMP-Activated Protein Kinases; Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Catalytic Domain; Cell Line; Tumor; Cell Proliferation; Down-Regulation; Enzyme Activation; Imidazoles; Phosphorylation; Piperazines; Pituitary Neoplasms; Rats; Ribonucleotides; Ribosomal Protein S6 Kinases; 70-kDa; Sirolimus; TOR Serine-Threonine Kinases; Endocrinology; Diabetes and Metabolism; Endocrine and Autonomic Systems; Cellular and Molecular Neuroscience; Medicine (all)